| Tag | Content |
|---|
EnhancerAtlas ID | HS134-00553 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr1:23956190-23956710 |
Target genes | | Number: 11 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HES2 | MA0616.2 | chr1:23956371-23956381 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr1:23956371-23956381 | GGCACGTGCC | - | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10300 | chr1:23954989-23956392 | CD19_Primary | | SE_11050 | chr1:23936367-23956768 | CD20 | | SE_18996 | chr1:23955115-23956545 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_58372 | chr1:23873313-23964782 | Ly1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 23956406 | 23956539 | | chr1 | 23956500 | 23956682 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I023628 | chr1 | 23955319 | 23956617 |
|
Enhancer Sequence | TAATAATAAT AATAATAATA ATATTGGTGA GGGCTGGGTG CGATGGCTGA TGCCTATAAT 60
CCCAGTACTT TGGGAGGCTG AGGTGGGTGG ATTGCTGGAA CACAGGACTT CAAAACCAAC 120
CTGGGCAACA TGGTGAGACC CTGGCTCTAC AAAAAAATTT TAAAAAGTAG CCCTGCATGG 180
TGGCACGTGC CTGTGGTCCC AGCTATGCAG GTGGCTGAAG TGGGAGGATG GCTTGAGCTC 240
AGGAGGTCAA GGCTACAGTG AACCGTGATC ATGCCACTGC ACTCTAGCCT GGCAGTCTGA 300
GGGAGACTGT TTCTATATTG CTGAGGATGT GGGTAGCTGG AGAGTCTCAG GCATTATCAG 360
TGAAAGTGTG AATTGCTATT ACCCTAGTGT GAGGCAAGTC CTTTGACTCC TGAATCCTCA 420
GTCTAGGAAT TTACCCTCAG GTAATTCTTA CCCAATGTCA AAAAGATGCA GGGATGTTCA 480
CGGAACTTTT TTTATAGTAG TGAAAAATTG GAAATGACAT 520
|
